Single Site, Single Subject, Treatment IND With Mannkind Corporation's Technosphere Inhalation System
Status:
Withdrawn
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this program is to allow patients with diabetes and with specific medical
needs which require them to use this investigational inhaled insulin product in order to
adequately manage their diabetes. Treatment use of this investigational product is only
anticipated when exceptional need is identified by a treating physician on a per patient case
by case review.